ClinicalTrials.gov
public full text
Public Domain
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
The study explores efficacy and safety of the lipid-lowering therapy with CRESTOR in statin-naive patients and in patients with previously unsuccessful statin therapy. This study was designed to investigate the dynamic of the lipid parameters and therapy tolerability during 8-10 weeks treatment with CRESTOR
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets#836012
- The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure#1125475
- Exercise And Rosuvastatin Treatment: Is There an Anti-Inflammatory Synergy?#1152073
- A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects#865881
- Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome#994808
Record · ID 981403
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive